🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/10/2012 | 11,07 | 11,15 | 10,87 | 11,04 | -0,73% | 2,59% | 81.913 |
| 05/10/2012 | 11,10 | 11,25 | 11,07 | 11,12 | +0,23% | 1,57% | 178.093 |
| 04/10/2012 | 10,92 | 11,10 | 10,78 | 11,10 | +2,12% | 2,97% | 109.806 |
| 03/10/2012 | 10,86 | 10,92 | 10,67 | 10,87 | +0,35% | 2,24% | 148.438 |
| 02/10/2012 | 10,69 | 10,90 | 10,67 | 10,83 | +1,52% | 2,22% | 134.652 |
| 01/10/2012 | 10,79 | 10,79 | 10,61 | 10,67 | -0,29% | 1,68% | 128.080 |
| 28/09/2012 | 10,95 | 10,97 | 10,70 | 10,70 | -2,83% | 2,45% | 183.864 |
| 27/09/2012 | 10,99 | 11,10 | 10,94 | 11,01 | +0,80% | 1,48% | 109.004 |
| 26/09/2012 | 11,03 | 11,03 | 10,77 | 10,92 | -0,74% | 2,38% | 90.890 |
| 25/09/2012 | 11,20 | 11,33 | 10,85 | 11,00 | -0,79% | 4,23% | 107.882 |
| 24/09/2012 | 11,38 | 11,38 | 11,02 | 11,09 | -3,16% | 3,23% | 104.676 |
| 21/09/2012 | 11,62 | 11,63 | 11,34 | 11,45 | -0,38% | 2,58% | 237.244 |
| 20/09/2012 | 11,55 | 11,59 | 11,29 | 11,50 | -0,97% | 2,65% | 58.990 |
| 19/09/2012 | 11,83 | 11,83 | 11,38 | 11,61 | -1,22% | 3,85% | 138.660 |
| 18/09/2012 | 11,47 | 11,85 | 11,46 | 11,75 | +2,06% | 3,43% | 167.033 |
| 17/09/2012 | 10,95 | 11,53 | 10,91 | 11,52 | +5,12% | 5,64% | 184.666 |
| 14/09/2012 | 11,02 | 11,10 | 10,94 | 10,95 | -0,11% | 1,41% | 97.302 |
| 13/09/2012 | 10,92 | 11,05 | 10,85 | 10,97 | +0,23% | 1,77% | 105.638 |
| 12/09/2012 | 10,99 | 11,22 | 10,69 | 10,94 | +0,00% | 4,88% | 144.270 |
| 11/09/2012 | 11,18 | 11,18 | 10,82 | 10,94 | -1,79% | 3,18% | 152.926 |
| 10/09/2012 | 11,64 | 11,64 | 11,07 | 11,14 | -4,29% | 4,88% | 111.409 |
| 07/09/2012 | 11,70 | 11,76 | 11,52 | 11,64 | -0,37% | 2,08% | 173.284 |
| 06/09/2012 | 11,45 | 11,75 | 11,39 | 11,68 | +3,08% | 3,10% | 298.158 |
| 05/09/2012 | 11,09 | 11,35 | 10,97 | 11,34 | +2,02% | 3,38% | 157.735 |
| 04/09/2012 | 10,77 | 11,17 | 10,68 | 11,11 | +3,01% | 4,58% | 89.928 |
| 31/08/2012 | 10,89 | 10,89 | 10,63 | 10,79 | +0,00% | 2,41% | 132.248 |
| 30/08/2012 | 10,34 | 10,99 | 10,34 | 10,79 | +3,41% | 6,34% | 178.574 |
| 29/08/2012 | 10,24 | 10,56 | 10,24 | 10,43 | +2,20% | 3,04% | 62.196 |
| 28/08/2012 | 10,31 | 10,38 | 10,12 | 10,21 | -1,15% | 2,48% | 79.669 |
| 27/08/2012 | 10,27 | 10,39 | 10,07 | 10,32 | +1,22% | 3,04% | 55.624 |